Solara Active Pharma Sciences Announces Record Date for Second & Final Call
Solara Active Pharma Sciences Limited has set April 02, 2026, as the record date for its Second and Final Call on partly paid-up equity shares. The call amount is ₹112.50 per share.
This is a procedural announcement related to a call on existing partly paid-up shares, which is a predetermined financial obligation for some shareholders. It does not represent a new business development or a change in the company's core operations or financial health.
The announcement is a routine procedural update regarding a call on partly paid-up shares and does not contain any new financial performance data or strategic developments that would significantly alter the company's outlook.
Solara Active Pharma Sciences Limited has announced the record date for the Second and Final Call on its partly paid-up equity shares. The call is for ₹112.50 per equity share, comprising ₹3.00 towards face value and ₹109.50 towards securities premium.
The record date for determining eligible shareholders for this call has been set for Thursday, April 02, 2026. This announcement follows up on a previous communication dated March 24, 2026, regarding the call.
Copies of the advertisements published in 'Business Standard' and 'Pratahkal' on March 25, 2026, informing shareholders about the Second and Final Call and the record date, have been submitted to the stock exchanges. These advertisements are also available on the company's website.
What to do with a filing like this
Solara Active Pharma Sciences Limited filed this with the NSE as a statutory disclosure, categorised under equity fundraising. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Solara Active Pharma Sciences Limited. Read the original for the full detail.